Ritsumeikan University Researcher Database
日本語>>
TOP page
TOP page
> MASAKI SO
（Last updated : 2021-07-15 19:35:30）
MASAKI SO
Department / Course
College of Pharmaceutical Sciences Department of Pharmacy
Title / Position
Assistant Professor
Achievement
Other Affiliations
Profile
Academic background
Business career
Committee and society
Research activities
Qualification and license
Subject of research
Research summary
Research summary(Photo/Image)
Present specialized field
research
Books
Papers
Others
Academic conference presentation
Other research achievements
Works
Winning science prize
Grants-in-Aid for Scientific Research -KAKENHI-
Competitive grants, etc. (exc. KAKENHI)
Achievements of joint.Funded research
Acquisition patent
Ritsumeikan Research Funding
teaching
Subject
Teaching achievements
social activity
Activity in society
Research exchange preferred theme
Others
Message
Home Page
E-Mail Address
Department laboratory expense researcher number
researchmap Researcher code
External Researcher ID
Academic background
1.
～2008
Master Course │ Medical Science Major │ Graduate School of Medicine │ Kyoto University │ Completed
2.
～2012
Doctorial Course │ Medicine Major │ Graduate School of Medicine │ Kyoto University │ Completed
3.
│ Kyoto University Ph.D. (Medical Science)
4.
～2006
Department of Chemical Pharmacology │ Faculty of Pharmaceutical Sciences │ Kyoto Pharmaceutical University │ Graduated
Present specialized field
Molecular biology, Cell biology, General medical chemistry, Biological pharmacy, Chemical biology
Papers
1.
2020
Multiple nuclear localization sequences in SRSF4 protein │ Genes Cells │ 25(5),pp.327-333 (Co-authored)
2.
2020
The cysteine residue at 424th of pyruvate kinase M2 is crucial for tetramerization and responsiveness to oxidative stress │ Biochem. Biophys. Res. Commun. │ 526,pp.973-977 (Co-authored)
3.
2019
Myelodysplastic Syndrome-Associated SRSF2 Mutations Cause Splicing Changes by Altering Binding Motif Sequences │ Front. Genet. │ 10 (338) (Co-authored)
4.
2015
Design and synthesis of a potent inhibitor of class 1 DYRK kinases as a suppressor of Adipogenesis │ Bioorg. Med. Chem. │ 1 (23 (15)),pp.4434-41 (Co-authored)
5.
2015
Identification of the specific interactors of the human lariat RNA debranching enzyme 1 protein │ Int. J. Mol. Sci. │ 9 (16 (2)),pp.3705-21 (Co-authored)
Display All（9）
Academic conference presentation
1.
2016/02/17
A splicing reporter-based method for screening of RNA splicing switch identifies the novel therapeutic targets for tumor-worsening proteins (10th AACR-JCA Joint Conference)
2.
2015/10/06
Chemical biology unveils the RNA splicing mechanism of functional proteins (The 2nd IFOM-Kyoto University Joint Symposium)
3.
2012/10/06
Deficiency of Thioredoxin binding protein-2 (TBP-2) enhances TGF-β signaling and promotes Epithelial to Mesenchymal Transition (京都大学グローバルCOEプログラム国際シンポジウム)
4.
2012/06/07
Deficiency of Thioredoxin binding protein-2 (TBP-2) enhances TGF- beta signaling
5.
2011/12/12
Deficiency of Thioredoxin binding protein-2 (TBP-2) enhances TGF- beta signaling and contributes to TGF-β-induced Epithelial to Mesenchymal Transition